African Traditional Medicine · African
Sutherlandia frutescens (Cancer Bush)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Sutherlandia frutescens contains L-canavanine and pinitol as primary bioactive compounds that modulate immune function through T-lymphocyte activation. This South African medicinal plant demonstrates immunomodulatory effects by enhancing cellular immunity while reducing inflammatory cytokine production.
Sutherlandia frutescens, commonly known as Cancer Bush, is a shrub native to Southern Africa. It is traditionally harvested from the wild and used in various forms, such as teas and capsules.
Preliminary studies suggest Sutherlandia frutescens may have immune-boosting properties and potential anti-cancer effects, but more rigorous research, including randomized controlled trials, is needed to validate these claims.
Typical dosage is 300-600 mg per day, often taken in capsule form. Consult a healthcare provider before use.
Sutherlandia frutescens (Cancer Bush) is not consumed as a macronutrient-dense food but rather as a medicinal herb, typically prepared as a tea or taken in capsule/tincture form. Its value lies primarily in its bioactive compound profile rather than caloric or macronutrient content. Key bioactive compounds include: **Amino acids:** L-canavanine (a non-protein amino acid, approximately 30–40 mg/g dry leaf weight), which exhibits antiviral and antitumor properties but also acts as an arginine analog that may interfere with protein synthesis at high doses; GABA (gamma-aminobutyric acid, approximately 10–14 mg/g dry weight), contributing to anxiolytic and calming effects; L-arginine (approximately 1–3 mg/g dry weight), supporting nitric oxide synthesis and cardiovascular function. **Triterpenoid saponins:** Sutherlandiosides A–D (cycloartane-type glycosides, collectively approximately 2–8 mg/g dry weight), which are considered marker compounds unique to this species and are associated with anti-inflammatory and anticancer activity. **Flavonoids:** Sutherlandins A–D (flavonol glycosides, approximately 1.5–6 mg/g dry weight), providing antioxidant capacity with moderate bioavailability enhanced by co-occurring organic acids. **Pinitol (D-pinitol):** Approximately 10–15 mg/g dry weight, a cyclitol with documented hypoglycemic and anti-inflammatory properties; bioavailability is relatively high when taken orally. **Polyphenols and tannins:** Total phenolic content approximately 25–50 mg gallic acid equivalents per gram dry weight, contributing significant free radical scavenging activity (ORAC values comparable to green tea). **Minerals:** Contains trace amounts of iron (approximately 0.3–0.8 mg/g), zinc (approximately 0.02–0.05 mg/g), magnesium (approximately 1.5–3.0 mg/g), potassium (approximately 8–15 mg/g), and calcium (approximately 5–10 mg/g) in dried leaf material; mineral bioavailability may be partially reduced by tannin content. **Vitamins:** Minor amounts of vitamin C (approximately 0.5–1.5 mg/g dry weight) and traces of B-vitamins. **Fiber:** Dried leaf material contains roughly 15–20% crude fiber, though this is largely irrelevant in tea preparations. **Protein:** Approximately 8–12% crude protein in dry leaf, mostly relevant only in powdered whole-leaf preparations. **Bioavailability notes:** L-canavanine and pinitol demonstrate good oral bioavailability; flavonol glycosides (sutherlandins) require partial hydrolysis in the gut for absorption; cycloartane saponins (sutherlandiosides) have moderate bioavailability but may be enhanced by the saponin-mediated increase in membrane permeability; GABA bioavailability across the blood-brain barrier is limited, though peripheral effects on the enteric nervous system are notable. Traditional preparation as a hot water infusion extracts approximately 40–60% of water-soluble bioactives.
L-canavanine acts as an arginine analog that influences nitric oxide synthase activity and T-cell proliferation. Pinitol functions as an insulin-mimetic compound that modulates glucose metabolism and reduces cortisol production. The plant's triterpenoid saponins suppress pro-inflammatory cytokines IL-1β and TNF-α while enhancing natural killer cell activity.
Limited clinical research exists, with most evidence from small pilot studies and traditional use documentation. A 12-week study of 24 HIV patients showed modest improvements in CD4+ T-cell counts and quality of life scores. Preliminary research in 18 cancer patients demonstrated reduced fatigue and improved appetite over 8 weeks. However, large-scale randomized controlled trials are lacking, and current evidence is considered preliminary.
Generally well-tolerated in traditional dosages, but L-canavanine may interfere with protein synthesis in high amounts. Potential interactions with immunosuppressive medications due to immune-stimulating effects. May affect blood sugar levels, requiring caution with diabetes medications. Pregnancy and breastfeeding safety is unknown due to insufficient research data.
